An email came today telling me of new
guidelines that have recently been published:
- Use of JAK
inhibitors in the management of myelofibrosis - revised
- Modification of
BCSH diagnostic criteria for essential thrombocythaemia
- Interim statement
BCSH CLL guideline
- Diagnosis and
management of Aplastic Anaemia
- Guidelines on the
identification and management of pre-operative anaemia
- Investigation and
management of Nodular Lymphocyte predominant Hodgkin's Lymphoma
Some are of direct relevance to me; others not so. But one of
the more informative emails I’ve received recently
No comments:
Post a Comment